EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$6.36
-0.03 (-0.47%)
Open$6.33
Previous Close$6.39
Day High$6.58
Day Low$6.32
52W High$12.16
52W Low$3.86
Volume—
Avg Volume1.22M
Market Cap418.84M
P/E Ratio—
EPS$-0.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+706.4% upside
Current
$6.36
$6.36
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 303.56M | 240.94M | 74.40M |
| Net Income | -52,749,653 | -37,681,314 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -27,507,528 | -20,741,449 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |